Thermo Fisher Scientific Introduces Ambient Shipping Solution for its Invitrogen™ Antibodies to Help Customers Reduce Packaging Waste and Carbon Emissions
New ambient temperature packaging represents a 90% reduction in shipment packaging mass
WALTHAM, Mass.--(BUSINESS WIRE)-- Thermo Fisher Scientific Inc., the world leader in serving science, today introduced more sustainable packaging for 125,000 of its Invitrogen™ antibodies. Transitioning from cold-chain packaging to ambient temperature shipping from distribution center to customer reduces package material mass, improves the customer experience and supports the company’s global sustainability efforts.
Through functional and stability testing, Thermo Fisher has demonstrated that a significant portion of its Invitrogen antibody portfolio can be maintained at ambient temperature conditions during transport. By eliminating the use of cold gel packs and introducing a new 100% curbside recyclable paper packaging for customers, Thermo Fisher expects to eliminate more than 216,000 pounds of paper and 440,000 pounds of gel ice packs per year. This new packaging represents a 90% reduction in shipment mass, improves freight density and reduces carbon emissions.
"Our ambient shipping initiative is a response to our customers' expectations and demonstrates our commitment to sustainability and innovation," said Ellie Mahjubi, vice president, protein cell analysis, Thermo Fisher Scientific. "We are proud to launch this critical change, delivering on Thermo Fisher's Mission to enable our customers to make the world healthier, cleaner and safer. We believe this transition will have a considerable impact on the global research community by reducing packaging waste and transport emissions without compromising the quality of our antibodies."
"Antibodies are important to our work in genetics and genomics," said Graham Erwin, assistant professor, molecular and human genetics, Baylor College of Medicine. "This more sustainable shipping solution helps simplify our laboratory's operations by reducing packaging waste and minimizing our environmental impact without compromising on our research goals."
A Sustainable Evolution of Packaging
The introduction of ambient shipping and Sustainable Forestry Initiative-certified packaging marks the latest advancements in Thermo Fisher’s commitment to more sustainable shipping. Thermo Fisher also ships many temperature sensitive products in a paper cooler as a more sustainable alternative to other coolers for products that still require shipping at low temperatures.
For more information on greener shipping, please visit the Thermo Fisher thermofisher.com/abambientshipping.
About Thermo Fisher Scientific
Thermo Fisher Scientific Inc. is the world leader in serving science, with annual revenue over $40 billion. Our Mission is to enable our customers to make the world healthier, cleaner and safer. Whether our customers are accelerating life sciences research, solving complex analytical challenges, increasing productivity in their laboratories, improving patient health through diagnostics or the development and manufacture of life-changing therapies, we are here to support them. Our global team delivers an unrivaled combination of innovative technologies, purchasing convenience and pharmaceutical services through our industry-leading brands, including Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services, Patheon and PPD. For more information, please visit www.thermofisher.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20241008982104/en/
Media Contact Information:
Name: Kristin Blake
Phone: 760-637-1166
E-mail: kristin.blake@thermofisher.com
Source: Thermo Fisher
Latest articles
-
What Labour’s Autumn Budget Means for the UK Life Sciences Industry
-
AbbVie and EvolveImmune Therapeutics Announce Collaboration and Option-to-License Agreement to Develop Next-Generation Cancer Biotherapeutics
-
Bristol Myers Squibb Presents New Long-term Data from the EMERGENT Program Evaluating COBENFY™ (xanomeline and trospium chloride) in Adults with Schizophrenia at Psych Congress 2024